Chemist + Druggist is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


How has the sector responded to the Boots MUR allegations?

RPS English Pharmacy Board chair Sandra Gidley says pressure to meet targets "directly contradicts" professional standards

Pharmacy Voice has defended the proper use of medicines use reviews (MURs) in the wake of claims made by the Guardian that Boots pressures its staff into conducting them unnecessarily for financial gain.

Pharmacy Voice chief executive Rob Darracott acknowledged that the newspaper's allegations against the multiple – including claims from one Boots pharmacist that they had been instructed to carry out an MUR on a patient with dementia – will raise concerns about the “potential waste” of NHS money.

But MURs are a “highly valuable” way of optimising medicines and their efficacy, Mr Darracott said yesterday (April 13). Pharmacists should be “proactive” in offering the service as often as possible, providing it is “clinically beneficial” for each patient, he added.

Boots responds to allegations

Boots told C+D yesterday that it “doesn’t recognise" the Guardian’s claims. The multiple has reminded its pharmacists of its guidance on providing MURs, which makes clear that they should only be offered if they benefit patients, and should never be carried out for the “attainment of numerical targets”, it added.

PSNC: Targets "a matter for" contractors

Pharmaceutical Services Negotiating Committee (PSNC) has told C+D that how contractors set priorities for staff is "a matter for them". But helping patients optimise their medicines should be the "priority for all involved in providing" MURs, director of NHS services Alastair Buxton said this afternoon (April 14). 

RPS: "Urgent need" to address target culture

The Royal Pharmaceutical Society (RPS) criticised the target culture caused by "unacceptable commercial pressures" in large pharmacy companies. 

English Pharmacy Board chair Sandra Gidley said the pressure to meet targets "directly contradict" regulatory and professional standards, and stressed that pharmacists should have "professional autonomy" at work.

MURs and the new medicine service (NMS) are "important" services, and the RPS is "unequivocal" that the vast majority of pharmacists use "precious" NHS resources as effectively as possible, she said this afternoon (April 14).


How often do you feel pressured to provide an MUR, regardless of whether it will benefit the patient?
More than once a day
Every day
Two or three times a week
Once a week
Once a month
Total votes: 1110

The Twitter reaction

Pharmacists took to Twitter to air their views on the Guardian's allegations.

Read more on the MUR abuse allegations:

C+D's Kristoffer Stewart on how MUR abuse is widespread

Dr Messenger reveals his own pressure to meet targets

Read readers' reaction to yesterday's story

GPhC to look into MUR abuse evidence


Have you ever felt pressured to carry out unnecessary services?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Related Content


Pharmacist Managers - Recruiting Now !
East London, Essex and Luton
£40,000 - £50,000 per year

Apply Now



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts